Financial Statements — HCMAW
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 0.65 | 0.08 | 0.14 | -- |
| Total Current Assets | 0.78 | 0.96 | 1.24 | -- |
| Total Non-current Assets* | 261.81 | 259.42 | 254.78 | -- |
| Total Assets | 262.59 | 260.39 | 256.03 | 0.42 |
| Total Current Liabilities | 1.53 | 0.90 | 0.11 | -- |
| Total Non-current Liabilities* | 13.25 | 13.25 | 13.25 | -- |
| Total Liabilities | 14.78 | 14.15 | 13.36 | 0.44 |
| Retained Earnings | (13.99) | (13.17) | (12.07) | (0.05) |
| Total Stockholder Equity | (13.99) | (13.17) | (12.07) | (0.02) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Selling, General & Admin | 0.83 | 0.39 | 0.14 | 0.05 |
| Operating Income | (0.83) | (0.39) | (0.14) | (0.05) |
| Net Income | 1.57 | 1.72 | 0.39 | (0.05) |
| Basic EPS | -- | -- | -- | (0.01) |
| Diluted EPS | -- | -- | -- | (0.01) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Operating Cash Flow | (0.16) | (0.19) | (1.43) |
| Investing Cash Flow | -- | -- | (253.00) |
| Financing Cash Flow | -- | -- | 255.58 |
